Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 18517501000001119 | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 52739501000001118 | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules (Martindale Pharmaceuticals Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Is a | Potassium phosphate 2mmol/mL injection solution 10mL ampule | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Is a | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Is a | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Potassium phosphate | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Potassium electrolyte | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Dipotassium hydrogen phosphate | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has specific active ingredient | Dipotassium hydrogen phosphate | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has dispensed dose form | Conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | VMP non-availability indicator | Re-introduced | true | Inferred relationship | Existential restriction modifier | ||
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Has specific active ingredient | Dipotassium hydrogen phosphate | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | Is pack of | False | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier | |
| Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | Has AMP | True | Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR